{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:28:55Z","timestamp":1789918135686,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jad.2014.01.006","type":"journal-article","created":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T17:03:15Z","timestamp":1390669395000},"page":"87-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Further evidence for plasma progranulin as a biomarker in bipolar disorder"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-5930","authenticated-orcid":false,"given":"Sarah","family":"Kittel-Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-9140","authenticated-orcid":false,"given":"Johannes","family":"Weigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Volkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Ge\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Olmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-1292","authenticated-orcid":false,"given":"Heike","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Kopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2014.01.006_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.01.006_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-4-7","article-title":"Progranulin in frontotemporal lobar degeneration and neuroinflammation","volume":"4","author":"Ahmed","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2014.01.006_bib3","doi-asserted-by":"crossref","DOI":"10.1159\/000352022","article-title":"Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a portuguese cohort","author":"Almeida","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jad.2014.01.006_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/prca.201100061","article-title":"Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection","volume":"6","author":"Alsaif","year":"2012","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.jad.2014.01.006_bib5","first-page":"461","article-title":"Neuroprotective action of lithium in disorders of the central nervous system","volume":"36","author":"Chiu","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jad.2014.01.006_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jad.2014.01.006_bib7","first-page":"145","article-title":"Progranulin: a novel regulator of gastrointestinal cancer progression","volume":"2","author":"Demorrow","year":"2013","journal-title":"Transl. Gastrointest. Cancer"},{"key":"10.1016\/j.jad.2014.01.006_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2014.01.006_bib9","series-title":"Leitfaden zur Erfassung des Psychopathologischen Befundes","year":"2007"},{"key":"10.1016\/j.jad.2014.01.006_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/brain\/awn352","article-title":"Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members","volume":"132","author":"Finch","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jad.2014.01.006_bib11","doi-asserted-by":"crossref","first-page":"e32164","DOI":"10.1371\/journal.pone.0032164","article-title":"Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia","volume":"7","author":"Galimberti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2014.01.006_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s13238-010-0067-1","article-title":"Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3beta","volume":"1","author":"Gao","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.jad.2014.01.006_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1212\/01.wnl.0000325058.10218.fc","article-title":"Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration","volume":"71","author":"Ghidoni","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2014.01.006_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.euroneuro.2008.07.005","article-title":"Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report","volume":"18","author":"Goodwin","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2014.01.006_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2012.12.023","article-title":"Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder","volume":"145","author":"Hope","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2014.01.006_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/npp.2012.231","article-title":"Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder","volume":"38","author":"Jakobsson","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.01.006_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0812429","article-title":"Insights into the role of progranulin in immunity, infection, and inflammation","volume":"93","author":"Jian","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jad.2014.01.006_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/mp.2009.39","article-title":"Neurobiological trait abnormalities in bipolar disorder","volume":"14","author":"Langan","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2014.01.006_bib19","series-title":"Diagnostisches Kurzinterview bei Psychischen St\u00f6rungen: Mini-DIPS","author":"Margraf","year":"1994"},{"key":"10.1016\/j.jad.2014.01.006_bib20","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1586\/ern.12.98","article-title":"Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?","volume":"12","author":"Mcnamara","year":"2012","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2014.01.006_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13554790903456209","article-title":"Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia","volume":"16","author":"Momeni","year":"2010","journal-title":"Neurocase"},{"key":"10.1016\/j.jad.2014.01.006_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.5551\/jat.3921","article-title":"HDL\/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins","volume":"17","author":"Okura","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.jad.2014.01.006_bib23","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1093\/hmg\/ddn257","article-title":"Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia","volume":"17","author":"Rademakers","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jad.2014.01.006_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2014.01.006_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2014.01.006_bib26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.1199214","article-title":"The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice","volume":"332","author":"Tang","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jad.2014.01.006_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1083\/jcb.200712039","article-title":"Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival","volume":"181","author":"Van Damme","year":"2008","journal-title":"J Cell Biol."},{"key":"10.1016\/j.jad.2014.01.006_bib28","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1074\/mcp.M800095-MCP200","article-title":"Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach","volume":"7","author":"Xu","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jad.2014.01.006_bib29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0092-8674(02)01141-8","article-title":"Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair","volume":"111","author":"Zhu","year":"2002","journal-title":"Cell"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T22:56:33Z","timestamp":1538866593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032714000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":29,"alternative-id":["S0165032714000214"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.01.006","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Further evidence for plasma progranulin as a biomarker in bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}